These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 38773448)
1. Metabolic self-feeding in HBV-associated hepatocarcinoma centered on feedback between circulation lipids and the cellular MAPK/mTOR axis. Zhu Y; Zhao Y; Ning Z; Deng Y; Li B; Sun Y; Meng Z Cell Commun Signal; 2024 May; 22(1):280. PubMed ID: 38773448 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade. Teng CF; Hsieh WC; Wu HC; Lin YJ; Tsai HW; Huang W; Su IJ PLoS One; 2015; 10(4):e0122373. PubMed ID: 25909713 [TBL] [Abstract][Full Text] [Related]
3. mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma. Mei L; Sun H; Yan Y; Ji H; Su Q; Chang L; Wang L Int J Biol Sci; 2024; 20(11):4178-4189. PubMed ID: 39247820 [TBL] [Abstract][Full Text] [Related]
4. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related]
5. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades. Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway. Qin X; Li C; Guo T; Chen J; Wang HT; Wang YT; Xiao YS; Li J; Liu P; Liu ZS; Liu QY J Exp Clin Cancer Res; 2017 Oct; 36(1):148. PubMed ID: 29052520 [TBL] [Abstract][Full Text] [Related]
7. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma. Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163 [TBL] [Abstract][Full Text] [Related]
8. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma. Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024 [TBL] [Abstract][Full Text] [Related]
9. Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma. Haberl EM; Weiss TS; Peschel G; Weigand K; Köhler N; Pauling JK; Wenzel JJ; Höring M; Krautbauer S; Liebisch G; Buechler C Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069902 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1. Chen Y; Zhao ZX; Huang F; Yuan XW; Deng L; Tang D J Cell Physiol; 2019 Apr; 234(4):3555-3569. PubMed ID: 30565670 [TBL] [Abstract][Full Text] [Related]
11. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2. Tian JH; Liu WD; Zhang ZY; Tang LH; Li D; Tian ZJ; Lin SW; Li YJ J Viral Hepat; 2019 Apr; 26(4):496-505. PubMed ID: 30521133 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B viral load affects prognosis of hepatocellular carcinoma. Yu SJ; Kim YJ World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype. Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897 [TBL] [Abstract][Full Text] [Related]
14. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways. Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231 [TBL] [Abstract][Full Text] [Related]
15. Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway. Wang R; Zhang D; Sun K; Peng J; Zhu W; Yin S; Tang D; Wu Y BMC Infect Dis; 2021 Jan; 21(1):56. PubMed ID: 33435880 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs associated with HBV infection and HBV-related HCC. Xie KL; Zhang YG; Liu J; Zeng Y; Wu H Theranostics; 2014; 4(12):1176-92. PubMed ID: 25285167 [TBL] [Abstract][Full Text] [Related]
17. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics. Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway. Bai PS; Hou P; Kong Y Exp Cell Res; 2018 Sep; 370(1):174-188. PubMed ID: 29928866 [TBL] [Abstract][Full Text] [Related]
19. New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors. Golob-Schwarzl N; Krassnig S; Toeglhofer AM; Park YN; Gogg-Kamerer M; Vierlinger K; Schröder F; Rhee H; Schicho R; Fickert P; Haybaeck J Eur J Cancer; 2017 Sep; 83():56-70. PubMed ID: 28715695 [TBL] [Abstract][Full Text] [Related]
20. HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models. Torresi J; Tran BM; Christiansen D; Earnest-Silveira L; Schwab RHM; Vincan E BMC Cancer; 2019 Jul; 19(1):707. PubMed ID: 31319796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]